Who are sodium hyaluronate 0.18%'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): carboxymethylcellulose 0.5% +glycerin 0.9%, Sodium Hyaluronate Ophthalmic 0.4%, methylcellulose 0.5%, Retaine™, TheraTears® Lubricant Eye Drop, Systane Ultra UD.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/sodium-hyaluronate-0-18.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

sodium hyaluronate 0.18% — Competitive Intelligence Brief

sodium hyaluronate 0.18% (sodium hyaluronate 0.18%) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Artificial tear / Ocular lubricant. Area: Ophthalmology.

marketed Artificial tear / Ocular lubricant Ophthalmology Small molecule Live · refreshed every 30 min

Target snapshot

sodium hyaluronate 0.18% (sodium hyaluronate 0.18%) — Allergan. Sodium hyaluronate is a viscoelastic substance that lubricates and protects the ocular surface by mimicking natural tear film.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class
sodium hyaluronate 0.18% TARGET	sodium hyaluronate 0.18%	Allergan	marketed	Artificial tear / Ocular lubricant
carboxymethylcellulose 0.5% +glycerin 0.9%	carboxymethylcellulose 0.5% +glycerin 0.9%	Allergan	marketed	Artificial tear / ocular lubricant
Sodium Hyaluronate Ophthalmic 0.4%	Sodium Hyaluronate Ophthalmic 0.4%	Laboratorios Sophia S.A de C.V.	marketed	Artificial tear / Ocular lubricant
methylcellulose 0.5%	methylcellulose 0.5%	Clinica Oftamologica Zona Sul	marketed	Artificial tear / Ocular lubricant
Retaine™	Retaine™	Ocusoft, Inc.	marketed	Artificial tear / ocular lubricant
TheraTears® Lubricant Eye Drop	TheraTears® Lubricant Eye Drop	University of Waterloo	marketed	Artificial tear / Ocular lubricant
Systane Ultra UD	Systane Ultra UD	Ocuwize LTD	marketed	Artificial tear / Ocular lubricant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Artificial tear / Ocular lubricant class)

Laboratorios Sophia S.A de C.V. · 7 drugs in this class
Allergan · 3 drugs in this class
University of Waterloo · 2 drugs in this class
University of California, Berkeley · 2 drugs in this class
Bp Consulting, Inc · 1 drug in this class
Chong Kun Dang Pharmaceutical · 1 drug in this class
Clinica Oftamologica Zona Sul · 1 drug in this class
Fundação Altino Ventura · 1 drug in this class
Medical University of South Carolina · 1 drug in this class
Ocuwize LTD · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). sodium hyaluronate 0.18% — Competitive Intelligence Brief. https://druglandscape.com/ci/sodium-hyaluronate-0-18. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab